Skip to main content
ViGenCell Inc. logo

ViGenCell Inc. — Investor Relations & Filings

Ticker · 308080 ISIN · KR7308080001 KO Professional, scientific and technical activities
Open in API
Filings indexed 134 across all filing types
Latest filing 2025-03-27 Board/Management Inform…
Country KR South Korea
Listing KO 308080

About ViGenCell Inc.

https://www.vigencell.com/en/

ViGenCell Inc. is a biotechnology company specializing in the development of immune cell therapies. The company focuses on creating treatments for cancer and other incurable diseases by enhancing a patient's own immunity. Its core technologies include the ViTier platform, which utilizes antigen-specific killer T cells to target and remove cancer cells, and the ViRanger platform, a T-cell gene therapy technology. These proprietary platforms form the basis of its pipeline of novel immune cell therapeutics designed to prolong life and improve patient outcomes.

Recent filings

Filing Released Lang Actions
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the CEO (Representative Director) of the company 'Vigencell'. It details the outgoing CEO, the incoming CEO, the reason for the change, and the date of the board resolution. This falls directly under the category of Board/Management Information (MANG).
2025-03-27 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from the company Vaxcell-Bio. It provides a summary of financial statements, audit opinions, and key financial metrics (assets, liabilities, equity, profit/loss) for the current and previous fiscal years. While it contains financial data, it is a standard regulatory disclosure of the audit results rather than the full Annual Report (10-K) or a standalone audit report document. In the context of Korean regulatory filings (DART system), this is a mandatory disclosure of the audit report submission, which falls under the category of Audit Report / Information. FY 2024
2025-03-19 Korean
사업보고서 (2024.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Vigencell' (바이젠셀). It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. It covers the fiscal year ending December 31, 2024. This is a comprehensive financial report, not an announcement or a summary, and fits the definition of an Audit Report/Information (AR) as it contains the auditor's opinion and the audited financial statements. FY 2024
2025-03-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Kim Tai Gyu) of Vigencell Co., Ltd. This type of filing, which reports personal share transactions or changes in ownership by company insiders, is classified as 'Director's Dealing' (DIRS) in the provided taxonomy.
2025-03-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) and Korea Exchange. It details changes in share ownership by a major shareholder (Kim Tai Gyu) due to the exercise of stock options. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant changes in ownership levels.
2025-03-13 Korean
주주총회소집공고
AGM Information Classification · 100% confidence The document is a formal 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Vigencell Co., Ltd. It details the meeting date, location, agenda items (financial statement approval, director appointments, etc.), and provides management reference materials (business overview, industry outlook, and pipeline information) as required by law for shareholders. This document is the comprehensive information package provided to shareholders for the AGM, not merely an announcement of the meeting.
2025-03-12 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.